Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 13Terminated 2Withdrawn 1Unknown 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 15Leukemia, Lymphocytic, Chronic, B-Cell 11Burkitt Lymphoma 10Lymphoma 9Leukemia 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Lymphoma, Follicular 8Lymphoma, Non-Hodgkin 7Lymphoma, Mantle-Cell 7Lymphoma, B-Cell, Marginal Zone 7Myelodysplastic Syndromes 6Multiple Myeloma 6Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Myeloproliferative Disorders 5Lymphoma, Large B-Cell, Diffuse 5Hodgkin Disease 5Lymphoma, Large-Cell, Immunoblastic 4Leukemia, Myelomonocytic, Chronic 4Leukemia, Myeloid, Chronic-Phase 4Leukemia, Myeloid, Accelerated Phase 4Hematologic Neoplasms 4Congenital Abnormalities 4Sezary Syndrome 3Mycosis Fungoides 3Lymphoma, T-Cell, Cutaneous 3Leukemia, Biphenotypic, Acute 3Waldenstrom Macroglobulinemia 2Recurrence 2Primary Myelofibrosis 2Neoplasms, Plasma Cell 2

Interventions

Peripheral Blood Stem Cell Transplantation 2Pentetic Acid 2fludarabine phosphate 1ethanolamine oleate 1Whole-Body Irradiation 1Trimethoprim, Sulfamethoxazole Drug Combination 1Trimethoprim 1Therapeutics 1Tacrolimus 1Sulfamethoxazole 1Sodium Chloride 1Saline Solution, Hypertonic 1Saline Solution 1Psychiatric Rehabilitation 1Pentostatin 1Ondansetron 1Mycophenolic Acid 1Minocycline 1Methotrexate 1In Situ Hybridization, Fluorescence 1Immunoenzyme Techniques 1Heparin 1Flow Cytometry 1Filgrastim 1Ethanol 1Edetic Acid 1Cytogenetic Analysis 1Cyclosporins 1Cyclosporine 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Leukemia, Neutrophilic, Chronic × fludarabine phosphate × Clear all
NCT00301912 2012-10-02

Busulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer

University of California, San Francisco

Phase 2 Withdrawn
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Pdgfra-Associated Chronic Eosinophilic Leukemia, Congenital Abnormalities, Anemia, Blast Crisis, Burkitt Lymphoma, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Neutrophilic, Chronic, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡